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Abstract: The aim of this study was to investigate the association of single nucleotide 
polymorphisms (SNPs) and haplotypes of potassium voltage-gated channel, KQT-like 
subfamily, member 1 (KCNQ1) with type 2 diabetes (T2D) in Malaysian Chinese subjects. 
The  KCNQ1 SNPs rs2237892, rs2283228 and rs2237895 were genotyped in 300 T2D 
patients and 230 control subjects without diabetes and metabolic syndrome. Two logistic 
regression models of analysis were applied, the first adjusted for age and gender while the 
second adjusted for age, gender and body mass index. The additive genetic analysis 
showed that adjusting for body mass index (BMI) even strengthened association of 
rs2237892, rs2283228 and rs2237895 with T2D (OR = 2.0, P = 5.1 × 10
−5; OR = 1.9,  
P = 5.2 × 10
−5; OR = 1.9, P = 7.8 × 10
−5, respectively). The haplotype TCA containing the 
allele of rs2237892 (T), rs2283228 (C) and rs2237895 (A) was highly protective against 
OPEN ACCESSInt. J. Mol. Sci. 2011, 12                 
 
5706
T2D (Second model; OR = 0.17, P = 3.7 × 10
−11). The KCNQ1 rs2237892 (TT), and the 
protective haplotype (TCA) were associated with higher beta-cell function (HOMA-B) in 
normal subjects (P = 0.0002; 0.014, respectively). This study found that KCNQ1 SNPs was 
associated with T2D susceptibility in Malaysian Chinese subjects. In addition, certain 
KCNQ1 haplotypes were strongly associated with T2D.  
Keywords: KCNQ1; SNPs; haplotype; diplotyps; type 2 diabetes 
 
1. Introduction  
The KCNQ1 gene has a total of 17 exons, spans 404 kb of chromosome sequence and is located on 
chromosome 11p15.5 [1]. KCNQ1 codes for the pore-forming alpha subunit of the voltage-gated K+ 
channel (KvLQT1) that is highly expressed in the heart. This channel plays an important role in 
controlling repolarization of the ventricles [2]. KCNQ1 is ubiquitously expressed in epithelial cells, 
including the endocrine and exocrine pancreatic cells [3]. KCNQ1 was reported to be expressed in 
insulin-secreting cells, and inhibition of this potassium channel has been shown to significantly 
increase insulin secretion [4].  
Genome wide association study (GWAS) has been applied to complex diseases, including T2D and 
has resulted in the identification of a growing number of trait susceptibility loci for T2D [5].   
Two independent GWAS have identified KCNQ1 as a novel T2D susceptibility gene in East Asian 
subjects [6,7]. More recently, two GWAS on Chinese Han and European populations confirmed 
KCNQ1 as T2D susceptibility gene [8,9]. The association of T2D with KCNQ1 variants was replicated 
in studies among Chinese [10–12], Singaporean [13,14], Indians [15], Pakistani [16] and in some  
Euro-Caucasians [6,17,18]. However, there is little data about the association of haplotypes of KCNQ1 
with T2D. The focus of this study was on the association of common variants of KCNQ1  
single nucleotide polymorphisms (SNPs) (rs2237892, rs2283228 and rs2237895), haplotypes and 
diplotypes with T2D in Malaysian Chinese subjects. 
2. Results  
Three hundred and forty-eight T2D and 354 control subjects who gave informed consent forms 
were recruited for this study. An application of the new metabolic syndrome criteria [19] on the 
control group resulted in 123 subjects with metabolic syndrome; therefore, they were excluded from 
the study. As a result of calculating % beta-cell insulin secretion using HOMA calculator, 3 diabetic 
and 1 normal subjects were excluded due to fasting insulin <20 pmol/L while 45 diabetic subjects were 
excluded due to fasting insulin >300 pmol/L. Consequently, 300 diabetic and 230 normal subjects 
without diabetes and metabolic syndrome were included in this study. The demography and 
biochemical parameters of the subjects are shown in Table 1.  Int. J. Mol. Sci. 2011, 12                 
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Table 1. Demography and biochemical parameters. 
Parameters 
Normal 
n = 230 
Type 2 diabetes 
n = 300 
P-value
Gender  
Male %  61.3  51 
Female %  38.7  49 
Family history of diabetes % 
Male %  32  76 
Female %  34  63 
Age (years)  52.9 ± 9.15  49.8 ± 7.42  <0.001
Height (m)  1.62 ± 0.08  1.63 ± 0.09  0.18
Weight (kg)  63.1 ± 15.5  75.0 ± 15.2  <0.001
BMI(kg/m
2)  24.1 ± 5.14  28.3 ± 5.15  <0.001
Waist (cm)  84.7 ± 13.1  95.7 ± 12.3  <0.001
Hip (cm)  99 ± 10.1  104 ± 10.1  0.001
Waist/Hip  0.85 ± 0.07  0.92 ± 0.07  <0.001
Systolic blood pressure  136 ± 18.5  136 ± 18.5  0.97
  81 ± 9.7  82 ± 10.5  0.20
Fasting insulin (pmol/L)  63.8 ± 44.6  103 ± 56.6  <0.001
Fasting glucose (mmol/L)  5.1 ± 0.49  8.3 ± 2.74  <0.001
Triacylglycerol (mmol/L)  1.1 ± 0.44  2.1 ± 1.20  <0.001
HDL cholesterol (mmol/L)  1.52 ± 0.32  1.21 ± 0.28  <0.001
Insulin resistance (IR)  1.4 ± 0.93  2.5 ± 1.44  <0.001
2.1. Association of KCNQ1 SNPs with T2D 
The SNPs included in this study did not deviate from the Hardy-Weinberg Equilibrium in the 
control group. The risk allele frequencies of rs2237892 (C), rs2283228 (A) and rs2237895 (C) in 
normal subjects were 0.69, 0.64 and 0.27 versus 0.78, 0.73 and 0.34 in diabetic patients, respectively. 
The first logistic regression model (adjusted for age and gender) showed that rs2237892, rs2283228, 
rs2237895 were associated with T2D (additive, OR = 1.6; 1.5; 1.5, P = 0.0005; 0.002; 0.004, 
respectively) (Table 2). Adjusting for body mass index (BMI) even strengthened the association of 
rs2237892, rs2283228, rs2237895 with T2D (additive, OR = 2.1; 1.9; 1.9, P = 5.1 × 10
−5, 5.2 × 10
−5, 
7.8 × 10
−5, respectively). Int. J. Mol. Sci. 2011, 12                 
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Table 2. Association of KCNQ1 single nucleotide polymorphisms with type 2 diabetes evaluated by recessive, dominant and additive   
genetic models. 
NPs Group  Genotype  n (distribution %) 
Recessive model  Dominant model  Additive model 
OR 
(95% CI) 
P-value 
OR 
(95% CI) 
P-value 
OR 
(95% CI) 
P-value 
First logistic regression model, analysis adjusted for age and gender 
rs2237892 
  TT   CT   CC  
1.9 
(1.29–2.66) 
0.001 
2.1 
(1.09–3.94) 
0.026 
1.6 
(1.25–2.18) 
0.0005  normal 27(11.7)  90(39.1)  113(49.1) 
diabetic 18(6.0)  99(33.0)  183(61.0) 
rs2283228 
  CC  AC  AA          
normal 33(14.3)  98(42.6)  99(43.0)  1.8 
(1.24–2.52) 
0.002 
1.7 
(0.97–2.93) 
0.06 
1.5 
(1.17–1.97) 
0.002 
diabetic 27(9.0)  105(35.0)  168(56.0) 
rs2237895 
  CC  AC  AA          
normal 14(6.1) 96(41.7)  120(52.2) 1.6 
(0.83–3.17) 
0.16 
1.7 
(1.17–2.39) 
0.004 
1.5 
(1.14–2.01) 
0.004 
diabetic 30(10.0) 147(49.0)  123(41.0) 
Second logistic regression model, analysis adjusted for age, gender, and body mass index 
rs2237892 *
 
  TT   CT   CC  
2.2 
(1.5–3.4) 
0.0002 
2.7 
(1.3–5.5) 
0.007 
2.0 
(1.4–2.7) 
5.1 × 10
−5  normal 27(12.6)  81(37.7)  107(49.8) 
diabetic 18(6.0)  99(33.0  183(61.0) 
rs2283228 * 
 CC  AC  AA 
2.3 
(1.5–3.5) 
7.3 × 10
−5 
2.2 
(1.2–4.1) 
0.011 
1.9 
(1.4–2.5) 
5.2 × 10
−5  normal 33(14.9)  89(40.3)  99(44.8) 
diabetic 27(9.0)  105(35.0)  168(56.0) 
rs2237895 * 
 CC  AC  AA 
3.7 
(1.7–8.1) 
0.001 
2.0 
(1.3–3.0) 
0.001 
1.9 
(1.4–2.7) 
7.8 × 10
−5  normal 11(5.0) 96(44.0)  111(50.9) 
diabetic 30(10.0) 147(49.0)  123(41.0) 
In the additive model, genotype of homozygote for the non-risk allele (0/0), heterozygote (1/0) and homozygote for the risk allele (1/1 were coded as  
0, 1 and 2 respectively). The recessive model was defined as 1/1 vs. 1/0 + 0/0 and dominant model as 1/1+1/0 vs 0/0; * The outlier (studentized residual is 
greater than 2.0 or less than −2.0) were excluded.  Int. J. Mol. Sci. 2011, 12                 
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2.2. Association of KCNQ1 Haplotypes and Diplotypes with T2D 
Three-SNP haplotypes and diplotypes block were identified with significant linkage   
disequilibrium (LD). This block was constructed from rs2237892, rs2283228 and rs2237895 (Figure 1). 
The possible haplotype for each individual was adjusted to more than 0.5 resulting in 8 haplotypes and 
23 diplotypes. The rare haplotypes (those below 2% frequency in cases or controls) were excluded 
from the analysis. Thus, 6 haplotypes and 8 diplotypes were further analyzed for their association  
with T2D.  
Figure 1. Pairwise linkage disequilibrium among KCNQ1 single nucleotide   
polymorphisms (SNPs) in Malaysian Chinese. Values in the upper represent KCNQ1 SNPs 
while values in the left represent D' value.  
 
The overall association of haplotypes with T2D was significant (P = 7.49 × 10
−6). The haplotype 
TCA containing the protective alleles of rs2237892, rs2283228 and rs2237895 is more frequent in  
the normal (0.33) compared to diabetic subjects (0.15). Both logistic regression models showed that 
this haplotype was strongly protective against T2D (first model, OR = 0.33, P = 8.4 × 10
−7; second 
model, OR = 0.17, P = 3.7 × 10
−11) (Table 3). The haplotype CAC containing the risk allele of the 
SNPs included in this study was the most frequent haplotype (0.44 in normal subjects vs. 0.51 in 
diabetic subjects). Second logistic regression models showed that this haplotype was a risk for T2D Int. J. Mol. Sci. 2011                 
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(OR = 1.7, P = 0.008) whereas the first model showed this haplotype as borderline risk for T2D  
(OR = 1.4, P = 0.057). 
Table 3. Association of common haplotypes with type 2 diabetes. 
Haplotypes 
rs2237892, 
rs2283228, 
rs2237895 
Frequency 
Odds 
ratio 
95% CI  P-Value 
 
Normal 
n (230) 
Type 2 
diabetes 
n (300) 
Overall  
P-value 
First logistic regression model, analysis adjusted for age and gender   
CAC 0.44  0.51  1.4  0.99–2.01  0.057 7.49  ×  10
−6a 
TCA 0.33  0.15  0.33  0.21–0.51  8.4 × 10
−7 
CAA 0.13  0.16  1.3  0.86–2.21  0.263 
CCA 0.05  0.04  0.7  0.30–1.63  0.41 
TAA 0.01  0.06  4.6  1.31–16.19 0.017 
CCC 0.02  0.07  3.2  1.20–8.81  0.021 
Second logistic regression model, analysis adjusted for age, gender and body mass index 
CAC *  0.44  0.51  1.7  1.1–2.4  0.008  
TCA *  0.34  0.15  0.17  0.1–0.28  3.7 × 10
−11 
CAA *  0.14  0.16  1.4  0.79–2.4  0.26 
CCA *  0.05  0.04  0.54  0.2–1.5  0.23 
TAA *  0.01  0.06  6.0  1.6–22.1  0.007 
CCC *  0.02  0.07  2.6  0.88–7.5  0.083 
* The outlier (studentized residual is greater than 2.0 or less than −2.0) were excluded; 
a non-adjusted 
overall P-value. 
The less frequent haplotype TAA (0.01 in normal vs. 0.06 in diabetic subjects was strongly 
associated with T2D (first model, OR = 4.6, P = 0.017; second model, OR = 6.0, P = 0.007). The 
results showed that haplotype CCC was significantly associated with T2D in the first logistic 
regression model (OR = 3.2, P = 0.021) whereas this significance was less evident in the second model 
(OR = 2.6, P = 0.083). Both logistic regression models showed that the haplotype CAA and CCA were 
no association with T2D.  
The overall association of diplotypes with T2D was significant (P = 8.1 × 10
−7). The diplotypes 
TCA-TCA and CAA-TCA containing the protective haplotype (TCA) showed a protection against 
T2D (first model, OR = 0.16, P = 8 × 10
−5; OR = 0.4, P = 0.0003, respectively) (second model,  
OR = 0.13, P = 4.4 × 10
−5; OR = 0.09, P = 2.9 × 10
−10, respectively) (Table 4). In addition, the second 
logistic regression model showed that the diplotype CAC-CAC containing the risk haplotype (CAC) 
was strongly a risk for T2D (OR = 3.9, P = 0.008) and diplotype CCA-CAC was a borderline risk for 
T2D (OR = 2.6, P = 0.07) whereas the first model did not show such effect. Both logistic regression 
models showed that the other diplotypes (CAA-CAC, CAA-CAA, TCA-CAC and CAA-CCA) were 
not significantly associated with T2D. Int. J. Mol. Sci. 2011                 
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Table 4. Association of common diplotypes with type 2 diabetes. 
Diplotypes  
rs2237892, 
rs2283228, 
rs2237895 
(Frequency) 
Odds 
ratio 
95% CI  P-Value 
 
Normal 
n (230) 
Type 2 
diabetes 
n (300) 
Overall  
P-value 
First logistic regression model, analysis adjusted for age and gender 
CAA-CAC 0.22 0.25  1.3  0.86–1.99  0.21  8.1  ×  10
−7a 
CAA-CAA 0.13 0.16  1.3  0.81–2.21  0.26 
CAA-TCA 0.18 0.09 0.4  0.21–0.63  0.0003 
TCA-CAC 0.13 0.12 0.92  0.54–1.57  0.77 
TCA-TCA 0.12 0.02 0.16  0.06–0.40  8 × 10
−5 
CAC-CAC 0.03 0.06 2.2  0.85–5.74 0.104 
CAA-CCA 0.05 0.03 0.48  0.19–1.19  0.11 
CCA-CAC 0.04 0.06 1.8  0.78–4.10  0.17 
Second logistic regression model, analysis adjusted for age, gender, and body mass index 
CAA-CAC *  0.23  0.25  1.4  0.79–2.4  0.26   
CAA-CAA *  0.14  0.16  1.3  0.82–1.3  0.26   
CAA-TCA *  0.19  0.08  0.09  0.04–0.18  2.9 × 10
−10  
TCA-CAC *  0.14  0.12  1.0  0.54–1.7  0.88   
TCA-TCA *  0.12  0.02  0.13  0.05–0.34  4.4 × 10
−5  
CAC-CAC *  0.01  0.06  3.9  1.4–10.9  0.008  
CAA-CCA *  0.05  0.03  0.38  0.12–1.2  0.09   
CCA-CAC *  0.03  0.06  2.6  0.92–7.5  0.07   
* The outlier (studentized residual is greater than 2.0 or less than −2.0) were excluded;   
a , non-adjusted overall P-value. 
2.3. Impact of KCNQ1 SNPs, Haplotypes and Diplotypes on Beta-Cell Function in Normal Subjects  
Two general linear models (GLM), the first adjusted for age and gender and the second adjusted for 
age, gender and BMI were approached to identify potential mediators who link the KCN Q1 variants, 
with T2D. The three SNPs were tested for their associations with diabetes-related quantitative traits, 
beta cell function (HOMA-B). Both GLM models showed that HOMA-B in normal subjects those had 
the variant of KCNQ1 rs2237892 (TT) was higher than CC and CT genotype (P = 0.002, 0.0002, 
respectively) (Table 5). The second GLM showed little effect of rs2283228 CC genotype on   
HOMA-B (P = 0.034) compared to other genotypes of this SNP. The results showed that rs2237895 
had no effect on beta-cell function.  
 Int. J. Mol. Sci. 2011, 12                 
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Table 5. 3 Impact of KCNQ1, haplotypes and diplotypes on beta-cell function (HOMA-B) in normal subjects. 
 
Non adjusted 
HOMA-B 
means(CI) 
Adjusted for age, gender  Adjusted for age, gender, BMI 
HOMA-B 
mean(CI) 
Parameter 
estimate 
P-value 
Univariate
P-value 
HOMA-B 
Mean(CI) 
Parameter 
estimate 
P-value 
Univariate 
P-value 
rs2237892 
CC(n = 113)  96(90–103)  98(92–105)  0.006  0.002  100(95–106)  0.01  0.0002 
CT(n = 90)  94(87–101)  92(85–98)  0.0004  90(85–96)  0.0003 
TT(n = 27) Ref  120(104–137)  121(106–138)    118(105–132)   
rs2283228 
AA(99) 97(90–104)  97(90–104)  0.33  0.584  102(96–109)  0.80  0.034 
AC(98) 97(87–101)  97(90–103)  0.30  92(86–97)  0.039 
CC(33) Ref  104(92–118)  104(92–118)    104(94–115)   
rs2237895 
CC(14)   100(83–122)  98(81–119)  0.91  0.74  106(90–125)  0.36  0.554 
AC(96) 95(88–102)  96(89–103)  0.44  96(91–103)  0.70 
AA(120) Ref  100(94–107)  99(93–106)     98(93–104)    
haplotypes 
CAA(n = 30)  84(74–95)  85(75–97)  0.001  0.003  90(81–100)  0.007  0.014 
CAC(n = 102)  97(91–104)  97(91–104)  0.026  97(92–103)  0.026 
TCA(n = 75) Ref  111(103–120)  110(102–119)    107(101–115)   
Diplotype 
CAA-CAA(n = 30)  84(75–94)  85(76–95)  4.0 × 10
−5  1.5 × 10
−6  90(81–99)  0.0001  5.7 × 10
−6 
CAA-CAC(n = 51)  106(97–115)  107(98–116)  0.12  110(102–119)  0.20 
CAA-TCA(n = 42)  117(107–129)  114(104–126)  0.55  105(96–115)  0.062 
TCA-CAC(n = 30)  83(75–93)  84(75–94)  1.9 × 10
−5  85(77–94)  5.8 × 10
−6 
TCA-TCA(n = 27) 
Ref 
120(106–134) 120(107–135)    120(108–133)   
% beta-cell insulin secretion was log-transformed before analyses, and the data were presented as geometric means; Ref, reference, the protective genotype, 
haplotypes and diplotypes were selected to be a reference for the comparison; CI, confidence interval. Int. J. Mol. Sci. 2011, 12                 
 
5713
Three haplotypes (CAA, CAC and TCA) and 5 diplotypes (CAA-CAA, CAA-CAC, CAA-TCA, 
TCA-CAC and TCA-TCA) fitted the criteria of parametric analysis (count ≥ 25) to evaluate their 
impact on the beta-cell function. Both GLM showed that HOMA-B was higher in normal subjects, 
which had the protective haplotype TCA than those normal subjects carrying the risk haplotyype CAC 
or CAA (P = 0.003; 0.014, respectively). Furthermore, the two protective diplotype (TCA-TCA, and 
CAA-TCA) showed a higher HOMA-B than the other diplotypes (first GLM, P = 1.5 × 10
−6; second 
GLM, P = 5.7 × 10
−6). 
3. Discussion 
The association of KCNQ1 SNPs, haplotypes and diplotypes with T2D among Malaysian Chinese 
was studied. Common variants of KCNQ1 SNPs rs2237892, rs2283228 and rs2237895 were selected 
for this study based on the Unoki and Yasuda findings [6,7] that these SNPs showed an association 
with T2D in Asian populations. The present study found that the common KCNQ1 SNPs rs2237892, 
rs2237895 and rs2283228 were strongly associated with T2D, which is in agreement with previous 
reports [6–15,18,20,21]. Adjusting for BMI even strengthened the association of KCNQ1 variants with 
T2D. The odds ratios of the second logistic regression model were 1.9–3.7 (additive genetic analysis) 
which are higher than the previous reported odds ratios (1.2–1.6) [6–15,18,20,21].  
The haplotypes and diplotypes showed a higher association with T2D than single individual SNPs 
did. Plotting the second logistic regression odds ratios and 95% CI of the association of SNPs (additive 
genetic models), haplotypes and diplotypes with T2D resulted in, the reciprocal 95% CI of the more 
associated haplotype (TAA) and diplotypes (CAA-TCA and TCA-TCA) were higher than 95% CI of 
individual SNPs, and were not overlapping each other (Figure 2). Other haplotype blocks have been 
reported to be associated with T2D [11,12,15]. 
Figure 2. Odds ratios and 95% confidence intervals of the association of individual SNPs 
(additive genetic models), haplotypes and diplotypes with T2D. Left number, odds ratio; 
bar, 95% confidence interval; * reciprocal odds ratio and 95% confidence interval   
were represented. 
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The current study confirmed the association of the KCNQ1 variants with impaired b-cell function 
estimated by HOMA-B, and the risk alleles of rs2237892 and rs2283228 were significantly associated 
with lower HOMA-B values. This finding is in agreement with a previous report [12]. The increased 
risk for T2D linked to KCNQ1 gene is likely to be caused by a reduction in insulin secretion [10–13]. 
The pore-forming alpha subunit of the voltage-gated K+ channel (KvLQT1) (encoded by KCNQ1) and 
the regulatory beta subunit ISK (encoded by potassium channel, voltage-gated, ISK-related subfamily, 
member 1; KCNE1 gene) co-assemble to form the I(KS) potassium channel in the pancreas [22]. 
Intrinsically, there is a possibility that KCNQ1 polymorphisms alter the role of the I(KS) potassium 
channel, causing decreased insulin secretion, leading in time to T2D [13]. However, homozygous 
Kcnq1
−/− mice have been reported not to show hyperglycaemia or glucose intolerance, and the 
contribution of the kcnq1-encoded protein to the molecular pathogenesis of T2D remains unclear [6]. 
A recent study, found that both blood glucose and insulin levels were lower in kcnq1
–/– than in 
kcnq1
+/+mice and the uptake of glucose
  into skeletal muscle, liver, kidney and lung tissue was 
significantly
 higher in kcnq1
–/– than inkcnq1
+/+mice [23] leading to a suggestion that kcnq1 is a novel
 
molecule affecting insulin sensitivity.  
4. Materials and Methods 
4.1. Subjects and Data Collection 
T2D Malaysian Chinese subjects aged between 30 and 70 years who attended the University 
Malaya Medical Centre (UMMC), Kuala Lumpur for treatment were randomly approached and asked 
to participate voluntarily in this study (target group). For the control group, the physically normal 
Malaysian Chinese subjects who attended the UMMC for routine medical check-ups were approached. 
The study was approved by the Medical Ethics Committee of the University of Malaya Medical 
Centre. Venous Blood (10 mL) was collected from each subject after obtaining written consent.  
4.2. Biochemical Analyses  
Glucose, triacylglycerol, total cholesterol and HDLc were measured by an automated analyzer 
(Dimension
® RxL Max
® Integrated Chemistry System), and insulin was measured by ADVIA Centaur 
assay XP Immunoassay System (Siemens Healthcare Diagnostics Inc. Deerfield, IL USA). % beta-cell 
insulin secretion (HOMA-B) was calculated using the Homeostasis Model Assessment (HOMA2) 
Calculator v2.2, which is available online from Oxford Center for Diabetes, Endocrinology and 
Metabolism.  
4.3. Genetic Analyses  
Single nucleotide polymorphisms of KCNQ1; rs2237892, rs2283228 and rs2237895 were selected 
for genotypic analysis in Malaysian T2D subjects based on the findings of Unoki and Yasuda [6,7] that 
these SNPs are associated with T2D in Asian populations. The SNPs sequences were obtained from 
the database of the US National Library of Medicine [24]. Specific primers were designed for each 
SNP by FastPCR program. DNA extraction was achieved through the salt precipitation method. All 
SNPs were amplified using a 96 microwell plate StepOnePlus thermocycler (Applied Biosystems Inc, Int. J. Mol. Sci. 2011                 
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Foster City, USA). The SNPs rs2237892, rs2283228 and rs2237895 were genotyped by restriction 
enzymes BsoBI, BstNI and SmaI, respectively. Polyacrylamide gel electrophoresis (7%) was used for 
detection the digested product of the PCR amplicons. The Polyacrylamide gel was stained by 0.1 
µg/mL ethidium bromide for 5 minutes and then visualized by exposure to ultraviolet light in the gel 
imaging system (Infinity 3026, Vilber Lourmat, Marnela Valled, France). To confirm the restriction 
enzyme results, approximately 10% of each SNPs PCR amplicons (54 samples) was sequenced by 
automated DNA sequencer (3130xl Genetic Analyzer, Applied Biosystems, Foster City, CA, USA) 
using terminator cycle sequencing kit v3.1 (Applied Biosystems). The sequencing results were 
identical to the restriction enzymes’ results of rs2237892 and rs2237895 (kappa = 1) where the kappa 
was 0.932 for rs2283228.  
4.4. Statistical Analysis  
HelixTree 7.0 SNP and Variation Suite for Genetic Statistics (SVS) was used to study the linkage 
disequilibrium (LD) between SNP and construct haplotypes and diplotypes of related SNPs. The 
deviation from the Hardy-Weinberg Equilibrium was tested by De Finetti program [25]. The other 
statistical analyses were performed on SPSS version 11.5. Two logistic regression models were 
applied for the evaluation of associations of the KCNQ1 SNPs, recessive, dominant and additive 
genetic analysis and the association of haplotypes and diplotypes with T2D. The first model was 
adjusted for age and gender while the second model, adjusted for age, gender and body mass index.  
The overall association of haplotypes and diplotypes with T2D was evaluated by crosstabs   
(chi-square test). The impact of the KCNQ1 SNPs variants, haplotypes and diplotypes on beta-cell 
insulin secretion (HOMA-B), was evaluated by two general linear models (GLM). The first adjusted 
for age and gender while the second adjusted for age, gender and BMI. HOMA-B values were skewed 
and, therefore, normalized by logarithmic transformation. Means were subsequently back transformed 
for presentation as geometric means. 
5. Conclusions  
This study showed that KCNQ1 common variants were associated with T2D in Malaysian Chinese 
subjects. In addition, analysis of KCNQ1 haplotypes and diplotypes supported the association of 
KCNQ1 gene polymorphisms with T2D. Furthermore, KCNQ1 SNPs, haplotypes and diplotypes were 
associated with beta-cell function in normal subjects without diabetes and metabolic syndrome. 
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